Mitochondrial disease
Gene: ELAC2
In 5 patients from 3 unrelated families with combined oxidative phosphorylation deficiency-17 (COXPD17; 615440) manifest as severe infantile-onset hypertrophic cardiomyopathy, Haack et al. (2013) identified compound heterozygous or homozygous mutations in the ELAC2 gene (605367.0006-605367.0009). The initial mutations were found be exome sequencing. In addition to cardiomyopathy, which resulted in death in childhood in 3 patients, affected individuals had hypotonia, lactic acidosis, poor growth, and delayed psychomotor development. Biochemical studies in patient skeletal muscle showed decreased mitochondrial complex I activity; some cells also showed decreases in complex IV.Created: 26 Nov 2021, 2:21 a.m. | Last Modified: 26 Nov 2021, 2:21 a.m.
Panel Version: 0.661
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Combined oxidative phosphorylation deficiency 17, MIM#615440
Publications
Gene: elac2 has been classified as Green List (High Evidence).
Phenotypes for gene: ELAC2 were changed from to Combined oxidative phosphorylation deficiency 17, MIM#615440
Publications for gene: ELAC2 were set to
Mode of inheritance for gene: ELAC2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: ELAC2 was added gene: ELAC2 was added to Mitochondrial_AGHA_VCGS. Sources: Expert Review Green,Australian Genomics Health Alliance Mitochondrial Flagship,Victorian Clinical Genetics Services Mode of inheritance for gene: ELAC2 was set to Unknown